WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) released earnings for its first quarter that increased from last year and beat the Street estimates.
The company's bottom line came in at $185.69 million, or $0.95 per share. This compares with $88.66 million, or $0.46 per share, last year.
Excluding items, Biomarin Pharmaceutical Inc. reported adjusted earnings of $221 million or $1.13 per share for the period.
Analysts on average had expected the company to earn $0.95 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 14.8% to $745.15 million from $648.83 million last year.
Biomarin Pharmaceutical Inc. earnings at a glance (GAAP) :
-Earnings: $185.69 Mln. vs. $88.66 Mln. last year. -EPS: $0.95 vs. $0.46 last year. -Revenue: $745.15 Mln vs. $648.83 Mln last year.
-Guidance: Full year EPS guidance: $4.20 Full year revenue guidance: $3,100 Mln
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
